T.E.A. Study Three Days Ertapenem Versus Three Days Ampicillin- Sulbactam

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The aim of the study was to compare the activity (efficacy and safety) of Ertapenem administered according to a short treatment for three days versus a short treatment for three days with AS in patients with an community acquired IAI of mild to moderate severity.
Epistemonikos ID: 634c3936b9653582354478289990c78c3f1a8858
First added on: May 04, 2024